Propagation of functional estrogen receptor positive normal human breast cells in 3D cultures.


Journal

Breast cancer research and treatment
ISSN: 1573-7217
Titre abrégé: Breast Cancer Res Treat
Pays: Netherlands
ID NLM: 8111104

Informations de publication

Date de publication:
Jul 2019
Historique:
received: 15 02 2019
accepted: 09 04 2019
pubmed: 18 4 2019
medline: 26 11 2019
entrez: 18 4 2019
Statut: ppublish

Résumé

Understanding how differentiation, microenvironment, and hormonal milieu influence human breast cell susceptibility to malignant transformation will require the use of physiologically relevant in vitro systems. We sought to develop a 3D culture model that enables the propagation of normal estrogen receptor alpha (ER) + cells. We tested soluble factors and protocols for the ability to maintain progenitor and ER + cells in cultures established from primary cells. Optimized conditions were then used to profile estrogen-induced gene expression changes in cultures from three pathology-free individuals. Long-term representation of ER + cells was optimal in medium that included three different TGFβ/activin receptor-like kinase inhibitors. We found that omitting the BMP signaling antagonist, Noggin, enhanced the responsiveness of the PGR gene to estradiol exposure without altering the proportions of ER + cells in the cultures. Profiling of estradiol-exposed cultures showed that while all the cultures showed immediate and robust induction of PGR, LRP2, and IGFB4, other responses varied qualitatively and quantitatively across specimens. We successfully identified conditions for the maintenance and propagation of functional ER + cells from normal human breast tissues. We propose that these 3D cultures will overcome limitations of conventional 2D cultures of partially or fully transformed cell lines by sustaining normal endocrine function and growth regulation of the cell populations that comprise intact breasts.

Identifiants

pubmed: 30993572
doi: 10.1007/s10549-019-05229-5
pii: 10.1007/s10549-019-05229-5
doi:

Substances chimiques

Biomarkers, Tumor 0
Receptors, Estrogen 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

131-140

Subventions

Organisme : California Breast Cancer Research Program
ID : 21UB-8012
Organisme : California Breast Cancer Research Program
ID : 17UB-8708
Organisme : Avon Foundation for Women
ID : L1779

Auteurs

Peng Meng (P)

Environmental Genomics & Systems Biology, Lawrence Berkeley National Laboratory, Berkeley, CA, 94720, USA.

Marica Vaapil (M)

Environmental Genomics & Systems Biology, Lawrence Berkeley National Laboratory, Berkeley, CA, 94720, USA.

Abderrahmane Tagmount (A)

Physiological Sciences, University of Florida, Gainesville, FL, 32611, USA.

Alex Loguinov (A)

Physiological Sciences, University of Florida, Gainesville, FL, 32611, USA.

Chris Vulpe (C)

Physiological Sciences, University of Florida, Gainesville, FL, 32611, USA.

Paul Yaswen (P)

Environmental Genomics & Systems Biology, Lawrence Berkeley National Laboratory, Berkeley, CA, 94720, USA. P_Yaswen@lbl.gov.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH